Skip to main content
. Author manuscript; available in PMC: 2018 Nov 2.
Published in final edited form as: Pediatr Res. 2018 May 2;83(6):1136–1145. doi: 10.1038/pr.2018.44

Figure 1. Categorization of study subjects based on presence or absence of coronary artery abnormalities (CAAs) at diagnosis and duration of high-dose aspirin therapy (HDA).

Figure 1

Comparison of HDA duration between patients without CAAs at diagnosis (left) and patients with CAAs at diagnosis (right). Each point indicates one patient. Among the 1–7 day HDA group, the days of HDA were a mean of 3.75, median 3, with an interquartile range (IQR) of 2–5 days. Among the >7 days HDA group, the days of HDA were a mean of 17.78, median 18, and IQR 11–25 days.